MedTrace Logo

Observational Study, for Quality Assessment, of Sarcoma in European and Latin American Multidisciplinary NETWORK

NCT04181970 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-03-21

No results posted yet for this study

Summary

Post-authorisation, multicentric, observational, retrospective and prospective study to assess quality of care of sarcoma patients in expert and non-expert centers by analysing correlation of quality items and outcomes such as relapse free survival, overall survival, percentage of amputation, etc.

Expert pathology peer review will be performed to detect differences between expert and non-expert centers as well as differences in treatment and patient prognosis.

Tumor samples of 4 types of sarcoma would also be included in translational research to detect biomarkers and produce preclinical models.

Conditions

Interventions

OTHER

Quality assessment

There is no intervention on study subjects. A tumor review will be performed by expert centers.

Sponsors & Collaborators

  • Grupo Espanol de Investigacion en Sarcomas

    lead OTHER

Principal Investigators

  • Javier MARTIN-BROTO, MD · Salud de Madrid

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-06-30
Primary Completion
2026-09-30
Completion
2026-09-30

Countries

  • Argentina
  • Brazil
  • Costa Rica
  • France
  • Italy
  • Mexico
  • Peru
  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04181970 on ClinicalTrials.gov